Bertrand D. van Zelst

873 citations

26 papers · 603 indexed · h-index 14

Rheumatology top 5%
Public Health, Environmental and Occupational Health top 10%
Molecular Biology
Pediatrics, Perinatology and Child Health top 10%
Hematology top 10%

Co-authors: Róbert de Jonge Sandra G. Heil Rob Pieters Jan Lindemans Theo M. Luider Roland J. W. Meesters Ethan den Boer Anita C. S. Hokken‐Koelega
Topics: Folate and B Vitamins Research (7 papers)Acute Lymphoblastic Leukemia research (6 papers)Per- and polyfluoroalkyl substances research (4 papers)
Cited by: Rheumatology Hematology Environmental Chemistry
Journals: Blood PLoS ONE Environment International
Partner nations: Netherlands United States Belgium

In The Last Decade

Bertrand D. van Zelst

24 papers receiving 589 citations

Peers

Countries citing papers authored by Bertrand D. van Zelst

Since Specialization

Citations

This map shows the geographic impact of Bertrand D. van Zelst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand D. van Zelst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand D. van Zelst more than expected).

Fields of papers citing papers by Bertrand D. van Zelst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand D. van Zelst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand D. van Zelst. The network helps show where Bertrand D. van Zelst may publish in the future.

Co-authorship network of co-authors of Bertrand D. van Zelst

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand D. van Zelst. A scholar is included among the top collaborators of Bertrand D. van Zelst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand D. van Zelst. Bertrand D. van Zelst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study 2025 ·British Journal of Clinical Pharmacology ·Sam Schoenmakers,(unknown),(unknown),Michelle Broekhuizen,(unknown),A.H. Jan Danser,Irwin Reiss,Karel Allegaert,Sjoerd A.A. van den Berg,Bertrand D. van Zelst,Ron HN van Schaik,Philip DeKoninck,(unknown),(unknown),Sinno H. P. Simons,Birgit C. P. Koch	0
2	Poly- and perfluoroalkyl substances (PFAS) in the first 1000 days reduce linear growth, lean body mass and bone mineral density at age 3 years 2025 ·Clinical Nutrition ·(unknown),(unknown),Bertrand D. van Zelst,Sjoerd A.A. van den Berg,Anita C. S. Hokken‐Koelega	0
3	Early life poly- and perfluoroalkyl substance levels and adiposity in the first 2 years of life 2024 ·European Journal of Endocrinology ·(unknown),Bertrand D. van Zelst,(unknown),Sjoerd A.A. van den Berg,Anita Hokken-Koelega	1
4	Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important? 2023 ·JCO Precision Oncology ·Annelienke M. van Hulst,Martha A. Grootenhuis,(unknown),Raphaële R. L. van Litsenburg,(unknown),Bertrand D. van Zelst,Linda Broer,Saskia M.F. Pluijm,Rob Pieters,Marta Fiocco,Erica L T van den Akker,Marry M. van den Heuvel‐Eibrink	2
5	Ensuring quality in 17OHP mass spectrometry measurement: an international study assessing isomeric steroid interference 2023 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Chung Shun Ho,(unknown),Brian R. Cooke,(unknown),(unknown),Sjoerd A.A. van den Berg,Michaela F. Hartmann,(unknown),Tze Ping Loh,Yolanda B. de Rijke,Bertrand D. van Zelst,Stefan A. Wudy,(unknown),Ronda F. Greaves	1
6	Longitudinal poly- and perfluoroalkyl substances (PFAS) levels in Dutch infants 2021 ·Environment International ·(unknown),Bertrand D. van Zelst,Sjoerd A.A. van den Berg,(unknown),Manouk van der Steen,Anita C. S. Hokken‐Koelega	27
7	Global DNA (hydroxy)methylation is stable over time under several storage conditions and temperatures 2020 ·Epigenetics ·(unknown),(unknown),Bertrand D. van Zelst,Natanja Oosterom,Róbert de Jonge,Sandra G. Heil	22
8	The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia 2020 ·BMC Cancer ·Natanja Oosterom,Marta Fiocco,(unknown),Inge M. van der Sluis,Rob Pieters,Bertrand D. van Zelst,Desirée E.C. Smith,Marry M. van den Heuvel‐Eibrink,Róbert de Jonge,Sandra G. Heil	4
9	Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia 2019 ·PLoS ONE ·Natanja Oosterom,Róbert de Jonge,Desirée E.C. Smith,Rob Pieters,Wim J. E. Tissing,Marta Fiocco,Bertrand D. van Zelst,Marry M. van den Heuvel‐Eibrink,Sandra G. Heil	13
10	Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients 2019 ·Arthritis Research & Therapy ·(unknown),Bertrand D. van Zelst,Maurits C. F. J. de Rotte,Johanna M. W. Hazes,Róbert de Jonge,Sandra G. Heil	30
11	Inhibition of Tissue-Nonspecific Alkaline Phosphatase Attenuates Ectopic Mineralization in the Abcc6 Mouse Model of PXE but Not in the Enpp1 Mutant Mouse Models of GACI 2018 ·Journal of Investigative Dermatology ·Qiaoli Li,Jianhe Huang,Anthony B. Pinkerton,José Luís Millán,Bertrand D. van Zelst,Michael A. Levine,John P. Sundberg,Jouni Uitto	47
12	When results matter: reliable creatinine concentrations in hyperbilirubinemia patients 2018 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown),Bertrand D. van Zelst,(unknown),Yolanda B. de Rijke,Christian Ramakers	7
13	Simultaneous measurement of whole blood vitamin B1 and vitamin B6 using LC-ESI–MS/MS 2017 ·Journal of Chromatography B ·(unknown),Bertrand D. van Zelst,(unknown),(unknown),Yolanda B. de Rijke	28
14	A stable isotope dilution LC–ESI-MS/MS method for the quantification of pyridoxal-5′-phosphate in whole blood 2012 ·Journal of Chromatography B ·Bertrand D. van Zelst,Róbert de Jonge	13
15	A U–HPLC–ESI–MS/MS–Based Stable Isotope Dilution Method for the Detection and Quantitation of Methotrexate in Plasma 2012 ·Therapeutic Drug Monitoring ·Ethan den Boer,Sandra G. Heil,Bertrand D. van Zelst,Roland J. W. Meesters,Birgit C. P. Koch,M.L. te Winkel,Marry M. van den Heuvel‐Eibrink,Theo M. Luider,Róbert de Jonge	26
16	Maternal Global Methylation Status and Risk of Congenital Heart Diseases 2008 ·Obstetrics and Gynecology ·Lydi M.J.W. van Driel,Róbert de Jonge,Willem A. Helbing,Bertrand D. van Zelst,Jaap Ottenkamp,Eric A.P. Steegers,Régine P.M. Steegers‐Theunissen	39
17	Detection and allele-frequencies of the 833T>C, 844ins68 and a novel mutation in the cystathionine β-synthase gene 2004 ·Clinica Chimica Acta ·(unknown),Róbert de Jonge,Bertrand D. van Zelst,Raf Brouns,Jan Lindemans	11
18	Different PSA Assays Lead to Detection of Prostate Cancers with Identical Histological Features 2002 ·European Urology ·(unknown),Chris H. Bangma,B. G. Blijenberg,Bertrand D. van Zelst,Mark F. Wildhagen,Theodorus van der Kwast,Fritz H. Schröder	18
19	Discordant performance of assays for free and total prostate‐specific antigen in relation to the early detection of prostate cancer 2001 ·British Journal of Urology ·B. G. Blijenberg,(unknown),Bertrand D. van Zelst,Chris H. Bangma,Mark F. Wildhagen,Fritz H. Schröder	29
20	New developments in the standardization of total prostate-specific antigen 1999 ·Clinical Biochemistry ·B. G. Blijenberg,(unknown),Bertrand D. van Zelst,Arto E. Boeken Kruger,Fritz H. Schröder	7

About Bertrand D. van Zelst

Bertrand D. van Zelst is a scholar working on Rheumatology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health, having authored 26 papers that have together received 603 indexed citations. Recurring topics across this work include Folate and B Vitamins Research (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and Per- and polyfluoroalkyl substances research (4 papers). The work is most often cited by research in Rheumatology (178 citations), Hematology (94 citations) and Environmental Chemistry (58 citations). Bertrand D. van Zelst has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Róbert de Jonge, Sandra G. Heil, Rob Pieters, Jan Lindemans, Theo M. Luider, Roland J. W. Meesters, Ethan den Boer, Anita C. S. Hokken‐Koelega, Godefridus J. Peters and Gertjan J.L. Kaspers. Their work appears in journals such as Blood, PLoS ONE and Environment International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact